ConductScience.org, home

Paper28296763

Evaluating the immunogenicity and safety of a BiondVax-developed universal influenza vaccine (Multimeric-001) either as a standalone vaccine or as a primer to H5N1 influenza vaccine: Phase IIb study protocol.

van Doorn E and 7 others. Medicine (Baltimore), 2017. Cited by 40 papers, by iCite.

Cite this record

ConductScience Library. Evaluating the immunogenicity and safety of a BiondVax-developed universal influenza vaccine (Multimeric-001) either as a standalone vaccine or as a primer to H5N1 influenza vaccine: Phase IIb study protocol. Papers, record 28296763. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28296763

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Evaluating the immunogenicity and safety of a BiondVax-developed universal influenza vaccine (Multimeric-001) either as a standalone vaccine or as a primer to H5N1 influenza vaccine: Phase IIb study protocol.
PubMed
Journal
Medicine (Baltimore)
PubMed
Year
2017
PubMed
Publication types
Clinical Trial, Phase II, Journal Article, Multicenter Study, Randomized Controlled Trial
PubMed
Citations, by iCite
40
iCite
Relative citation ratio, by iCite
1.47
iCite
Revised in PubMed
2024-05-25
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1van Doorn EEva
2Liu HHeng
3Ben-Yedidia TTamar
4Hassin SShimon
5Visontai IIldiko
6Norley SStephen
7Frijlink HWHenderik W
8Hak EEelko

Source PubMed

Download CSV of authors

Topics19

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Influenza A Virus, H5N1 SubtypeMajor topic
Influenza VaccinesMajor topic
Influenza, HumanMajor topic
Adolescent
Adult
Cytokines
Double-Blind Method
Female
Flow Cytometry
Hemagglutination Inhibition Tests
Humans
Immunity, Cellular
Immunity, Humoral
Influenza A virus
Influenza B virus
Male
Middle Aged
Research Design
Young Adult

Source PubMed

Download CSV of topics

References24

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
118704954Vaccine adjuvants: current challenges and future approaches.J Pharm Sci2009https://conductscience.org/library/papers/18704954PubMed
210480833How to randomise.BMJ1999https://conductscience.org/library/papers/10480833PubMed
325844934Natural T Cell-mediated Protection against Seasonal and Pandemic Influenza. Results of the Flu Watch Cohort Study.Am J Respir Crit Care Med2015https://conductscience.org/library/papers/25844934PubMed
422286307Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans.Nat Med2012https://conductscience.org/library/papers/22286307PubMed
522318394Safety and immunogenicity of multimeric-001--a novel universal influenza vaccine.J Clin Immunol2012https://conductscience.org/library/papers/22318394PubMed
618338241Development of stable influenza vaccine powder formulations: challenges and possibilities.Pharm Res2008https://conductscience.org/library/papers/18338241PubMed
718034655Epitope-based vaccine against influenza.Expert Rev Vaccines2007https://conductscience.org/library/papers/18034655PubMed
825787138High-level cellular and humoral immune responses in Guinea pigs immunized intradermally with a heat-inactivated varicella-zoster virus vaccine.Clin Vaccine Immunol2015https://conductscience.org/library/papers/25787138PubMed
919906909A single-dose influenza A (H5N1) vaccine safe and immunogenic in adult and elderly patients: an approach to pandemic vaccine development.J Virol2010https://conductscience.org/library/papers/19906909PubMed
1025455990Effectiveness of seasonal influenza vaccine in community-dwelling elderly people: a meta-analysis of test-negative design case-control studies.Lancet Infect Dis2014https://conductscience.org/library/papers/25455990PubMed
1117451739Optimization and validation of an 8-color intracellular cytokine staining (ICS) assay to quantify antigen-specific T cells induced by vaccination.J Immunol Methods2007https://conductscience.org/library/papers/17451739PubMed
1218374680Complications of viral influenza.Am J Med2008https://conductscience.org/library/papers/18374680PubMed
1325590680Early estimates of seasonal influenza vaccine effectiveness - United States, January 2015.MMWR Morb Mortal Wkly Rep2015https://conductscience.org/library/papers/25590680PubMed
1414723616Influenza virus: immunity and vaccination strategies. Comparison of the immune response to inactivated and live, attenuated influenza vaccines.Scand J Immunol2004https://conductscience.org/library/papers/14723616PubMed
1524241247Effectiveness of influenza vaccine in patients on hemodialysis--a review.Med Sci Monit2013https://conductscience.org/library/papers/24241247PubMed
1620352064CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials.PLoS Med2010https://conductscience.org/library/papers/20352064PubMed
1715592819Detection of influenza virus: traditional approaches and development of biosensors.Anal Bioanal Chem2005https://conductscience.org/library/papers/15592819PubMed
1829027130Quality Issues Identified During the Evaluation of Biosimilars by the European Medicines Agency's Committee for Medicinal Products for Human Use.AAPS PharmSciTech2018https://conductscience.org/library/papers/29027130PubMed
1924056771Cellular immune correlates of protection against symptomatic pandemic influenza.Nat Med2013https://conductscience.org/library/papers/24056771PubMed
2022658928Immune markers and correlates of protection for vaccine induced immune responses.Vaccine2012https://conductscience.org/library/papers/22658928PubMed

See all 24 referencesDownload CSV of references

Cited by33

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 40 citations.

PMIDTitleJournalYearIn PapersSource
39596049Prokaryote- and Eukaryote-Based Expression Systems: Advances in Post-Pandemic Viral Antigen Production for Vaccines.Int J Mol Sci2024https://conductscience.org/library/papers/39596049PubMed
38362528Fighting flu: novel CD8+ T-cell targets are required for future influenza vaccines.Clin Transl Immunology2024https://conductscience.org/library/papers/38362528PubMed
38257777Sequential Immunizations with Influenza Neuraminidase Protein Followed by Peptide Nanoclusters Induce Heterologous Protection.Viruses2024https://conductscience.org/library/papers/38257777PubMed
37764217Nanoparticles Carrying Conserved Regions of Influenza A Hemagglutinin, Nucleoprotein, and M2 Protein Elicit a Strong Humoral and T Cell Immune Response and Protect Animals from Infection.Molecules2023https://conductscience.org/library/papers/37764217PubMed
37047339A Comparison of Etiology, Pathogenesis, Vaccinal and Antiviral Drug Development between Influenza and COVID-19.Int J Mol Sci2023https://conductscience.org/library/papers/37047339PubMed
36820263Self-assembled multiepitope nanovaccine based on NoV P particles induces effective and lasting protection against H3N2 influenza virus.Nano Res2023https://conductscience.org/library/papers/36820263PubMed
36560509Flagellin-Fused Protein Targeting M2e and HA2 Induces Innate and T-Cell Responses in Mice of Different Genetic Lines.Vaccines (Basel)2022https://conductscience.org/library/papers/36560509PubMed
35862754Controlled Human Infection Models To Accelerate Vaccine Development.Clin Microbiol Rev2022https://conductscience.org/library/papers/35862754PubMed
35857640An inactivated multivalent influenza A virus vaccine is broadly protective in mice and ferrets.Sci Transl Med2022https://conductscience.org/library/papers/35857640PubMed
35746794Influenza B: Prospects for the Development of Cross-Protective Vaccines.Viruses2022https://conductscience.org/library/papers/35746794PubMed
35455283Development of a Universal Epitope-Based Influenza Vaccine and Evaluation of Its Effectiveness in Mice.Vaccines (Basel)2022https://conductscience.org/library/papers/35455283PubMed
35195008Peptides for Vaccine Development.ACS Appl Bio Mater2022https://conductscience.org/library/papers/35195008PubMed
35174313Is a universal influenza vaccine feasible?Ther Adv Vaccines Immunother2019https://conductscience.org/library/papers/35174313PubMed
34579269An Overview of Influenza Viruses and Vaccines.Vaccines (Basel)2021https://conductscience.org/library/papers/34579269PubMed
34073996Targeting Antigens for Universal Influenza Vaccine Development.Viruses2021https://conductscience.org/library/papers/34073996PubMed
34066605Quantifying the Persistence of Vaccine-Related T Cell Epitopes in Circulating Swine Influenza A Strains from 2013-2017.Vaccines (Basel)2021https://conductscience.org/library/papers/34066605PubMed
33987075In silico design of a multi-epitope peptide construct as a potential vaccine candidate for Influenza A based on neuraminidase protein.In Silico Pharmacol2021https://conductscience.org/library/papers/33987075PubMed
33658348T cell epitope screening of Epstein-Barr virus fusion protein gB.J Virol2021https://conductscience.org/library/papers/33658348PubMed
32957468Progress in the Development of Universal Influenza Vaccines.Viruses2020https://conductscience.org/library/papers/32957468PubMed
32788837Multi-Epitope Peptide-Based and Vaccinia-Based Universal Influenza Vaccine Candidates Subjected to Clinical Trials.Malays J Med Sci2020https://conductscience.org/library/papers/32788837PubMed

See all 33 cited byDownload CSV of cited by

Genes7

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/28296763

GET https://conductscience.org/api/papers/v1/28296763/references?page=2